Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Liabilities and Shareholders Equity (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Liabilities and Shareholders Equity readings, the most recent being $1544.0 for Q1 2026.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 89.63% to $1544.0 in Q1 2026 year-over-year; TTM through Feb 2026 was $74497.0, a 51.34% decrease, with the full-year FY2025 number at $31880.0, down 44.23% from a year prior.
  • Liabilities and Shareholders Equity reached $1544.0 in Q1 2026 per CBIH's latest filing, down from $22131.0 in the prior quarter.
  • The five-year high for Liabilities and Shareholders Equity was $101842.0 in Q4 2023, with the low at $1544.0 in Q1 2026.
  • A 4-year average of $42435.4 and a median of $34766.0 in 2024 define the central range for Liabilities and Shareholders Equity.
  • Year-over-year, Liabilities and Shareholders Equity skyrocketed 31.76% in 2024 and then tumbled 89.63% in 2026.
  • Year by year, Liabilities and Shareholders Equity stood at $101842.0 in 2023, then plummeted by 65.86% to $34766.0 in 2024, then plummeted by 36.34% to $22131.0 in 2025, then crashed by 93.02% to $1544.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Liabilities and Shareholders Equity are $1544.0 (Q1 2026), $22131.0 (Q4 2025), and $18942.0 (Q3 2025).